ANA MARIA GONZALEZ PINTO ARRILLAGA-rekin lankidetzan egindako argitalpenak (5)

2024

  1. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis

    Molecular Psychiatry

2023

  1. Predicting bipolar disorder I/II in individuals at clinical high-risk: Results from a systematic review

    Journal of Affective Disorders, Vol. 325, pp. 778-786

  2. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

2022

  1. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis

    EClinicalMedicine, Vol. 36